nodes	percent_of_prediction	percent_of_DWPC	metapath
Prazosin—SLC22A3—Lamivudine—acquired immunodeficiency syndrome	0.0685	0.0928	CbGbCtD
Prazosin—ORM1—Saquinavir—acquired immunodeficiency syndrome	0.0661	0.0896	CbGbCtD
Prazosin—SLC22A1—Indinavir—acquired immunodeficiency syndrome	0.0541	0.0733	CbGbCtD
Prazosin—SLC22A1—Nelfinavir—acquired immunodeficiency syndrome	0.0525	0.0712	CbGbCtD
Prazosin—SLC22A2—Zidovudine—acquired immunodeficiency syndrome	0.0524	0.071	CbGbCtD
Prazosin—SLC22A1—Saquinavir—acquired immunodeficiency syndrome	0.0475	0.0644	CbGbCtD
Prazosin—ABCG2—Nelfinavir—acquired immunodeficiency syndrome	0.0446	0.0605	CbGbCtD
Prazosin—SLC22A2—Lamivudine—acquired immunodeficiency syndrome	0.0405	0.055	CbGbCtD
Prazosin—ABCG2—Saquinavir—acquired immunodeficiency syndrome	0.0403	0.0547	CbGbCtD
Prazosin—ABCG2—Ritonavir—acquired immunodeficiency syndrome	0.0403	0.0547	CbGbCtD
Prazosin—ABCG2—Zidovudine—acquired immunodeficiency syndrome	0.0387	0.0524	CbGbCtD
Prazosin—SLC22A1—Lamivudine—acquired immunodeficiency syndrome	0.0352	0.0477	CbGbCtD
Prazosin—ABCG2—Lamivudine—acquired immunodeficiency syndrome	0.0299	0.0406	CbGbCtD
Prazosin—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.0212	0.0288	CbGbCtD
Prazosin—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.0192	0.026	CbGbCtD
Prazosin—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.0166	0.0225	CbGbCtD
Prazosin—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.0161	0.0218	CbGbCtD
Prazosin—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.0145	0.0197	CbGbCtD
Prazosin—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.0145	0.0197	CbGbCtD
Prazosin—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.0139	0.0189	CbGbCtD
Prazosin—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.0108	0.0146	CbGbCtD
Prazosin—MT3—nerve—acquired immunodeficiency syndrome	0.00794	0.114	CbGeAlD
Prazosin—ORM1—saliva—acquired immunodeficiency syndrome	0.00449	0.0646	CbGeAlD
Prazosin—MT3—spinal cord—acquired immunodeficiency syndrome	0.00212	0.0306	CbGeAlD
Prazosin—MT3—lung—acquired immunodeficiency syndrome	0.00193	0.0278	CbGeAlD
Prazosin—MT3—nervous system—acquired immunodeficiency syndrome	0.00179	0.0257	CbGeAlD
Prazosin—KCNH7—nervous system—acquired immunodeficiency syndrome	0.00179	0.0257	CbGeAlD
Prazosin—MT3—central nervous system—acquired immunodeficiency syndrome	0.00172	0.0248	CbGeAlD
Prazosin—KCNH7—central nervous system—acquired immunodeficiency syndrome	0.00172	0.0248	CbGeAlD
Prazosin—HTR1A—blood plasma—acquired immunodeficiency syndrome	0.00148	0.0213	CbGeAlD
Prazosin—KCNH6—lung—acquired immunodeficiency syndrome	0.00137	0.0198	CbGeAlD
Prazosin—MT3—brain—acquired immunodeficiency syndrome	0.00137	0.0197	CbGeAlD
Prazosin—KCNH7—brain—acquired immunodeficiency syndrome	0.00137	0.0197	CbGeAlD
Prazosin—MT3—lymph node—acquired immunodeficiency syndrome	0.00132	0.019	CbGeAlD
Prazosin—KCNH6—nervous system—acquired immunodeficiency syndrome	0.00127	0.0183	CbGeAlD
Prazosin—KCNH6—central nervous system—acquired immunodeficiency syndrome	0.00123	0.0177	CbGeAlD
Prazosin—ADRA2A—blood plasma—acquired immunodeficiency syndrome	0.00104	0.0149	CbGeAlD
Prazosin—SLC22A2—digestive system—acquired immunodeficiency syndrome	0.000974	0.014	CbGeAlD
Prazosin—KCNH6—brain—acquired immunodeficiency syndrome	0.000973	0.014	CbGeAlD
Prazosin—ADRA1B—nervous system—acquired immunodeficiency syndrome	0.000721	0.0104	CbGeAlD
Prazosin—ORM1—blood—acquired immunodeficiency syndrome	0.000715	0.0103	CbGeAlD
Prazosin—ADRA1D—nervous system—acquired immunodeficiency syndrome	0.000705	0.0102	CbGeAlD
Prazosin—ADRA1B—central nervous system—acquired immunodeficiency syndrome	0.000694	0.01	CbGeAlD
Prazosin—ORM1—bone marrow—acquired immunodeficiency syndrome	0.000692	0.00997	CbGeAlD
Prazosin—ORM1—spinal cord—acquired immunodeficiency syndrome	0.000689	0.00993	CbGeAlD
Prazosin—ADRA1D—central nervous system—acquired immunodeficiency syndrome	0.000679	0.00978	CbGeAlD
Prazosin—SLC22A1—blood—acquired immunodeficiency syndrome	0.000655	0.00944	CbGeAlD
Prazosin—ORM1—lung—acquired immunodeficiency syndrome	0.000627	0.00904	CbGeAlD
Prazosin—SLC22A1—vagina—acquired immunodeficiency syndrome	0.000607	0.00875	CbGeAlD
Prazosin—ORM1—nervous system—acquired immunodeficiency syndrome	0.000581	0.00837	CbGeAlD
Prazosin—SLC22A3—vagina—acquired immunodeficiency syndrome	0.00058	0.00837	CbGeAlD
Prazosin—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.000577	0.00831	CbGeAlD
Prazosin—ORM1—central nervous system—acquired immunodeficiency syndrome	0.000559	0.00806	CbGeAlD
Prazosin—ADRA1B—brain—acquired immunodeficiency syndrome	0.000551	0.00794	CbGeAlD
Prazosin—SLC22A3—lung—acquired immunodeficiency syndrome	0.000549	0.00791	CbGeAlD
Prazosin—ADRA1D—brain—acquired immunodeficiency syndrome	0.000539	0.00777	CbGeAlD
Prazosin—CYP1A1—skin of body—acquired immunodeficiency syndrome	0.000534	0.0077	CbGeAlD
Prazosin—SLC22A1—nervous system—acquired immunodeficiency syndrome	0.000532	0.00767	CbGeAlD
Prazosin—ADRA1A—lymphoid tissue—acquired immunodeficiency syndrome	0.00053	0.00764	CbGeAlD
Prazosin—HTR1D—nervous system—acquired immunodeficiency syndrome	0.000527	0.0076	CbGeAlD
Prazosin—HTR1A—spinal cord—acquired immunodeficiency syndrome	0.000521	0.00751	CbGeAlD
Prazosin—SLC22A1—central nervous system—acquired immunodeficiency syndrome	0.000512	0.00738	CbGeAlD
Prazosin—SLC22A3—nervous system—acquired immunodeficiency syndrome	0.000508	0.00733	CbGeAlD
Prazosin—HTR1D—central nervous system—acquired immunodeficiency syndrome	0.000507	0.00731	CbGeAlD
Prazosin—ADRA1A—blood—acquired immunodeficiency syndrome	0.000499	0.00719	CbGeAlD
Prazosin—SLC22A3—central nervous system—acquired immunodeficiency syndrome	0.000489	0.00705	CbGeAlD
Prazosin—KCNH2—blood—acquired immunodeficiency syndrome	0.000482	0.00694	CbGeAlD
Prazosin—KCNH2—bone marrow—acquired immunodeficiency syndrome	0.000466	0.00672	CbGeAlD
Prazosin—KCNH2—spinal cord—acquired immunodeficiency syndrome	0.000464	0.00669	CbGeAlD
Prazosin—KCNH2—vagina—acquired immunodeficiency syndrome	0.000447	0.00644	CbGeAlD
Prazosin—HTR1A—nervous system—acquired immunodeficiency syndrome	0.000439	0.00633	CbGeAlD
Prazosin—ORM1—lymph node—acquired immunodeficiency syndrome	0.000429	0.00618	CbGeAlD
Prazosin—ABCG2—blood—acquired immunodeficiency syndrome	0.000429	0.00618	CbGeAlD
Prazosin—CYP1A1—digestive system—acquired immunodeficiency syndrome	0.000427	0.00616	CbGeAlD
Prazosin—HTR1A—central nervous system—acquired immunodeficiency syndrome	0.000423	0.0061	CbGeAlD
Prazosin—ABCG2—bone marrow—acquired immunodeficiency syndrome	0.000415	0.00598	CbGeAlD
Prazosin—ABCG2—spinal cord—acquired immunodeficiency syndrome	0.000413	0.00595	CbGeAlD
Prazosin—CYP1A1—blood—acquired immunodeficiency syndrome	0.000407	0.00586	CbGeAlD
Prazosin—SLC22A1—brain—acquired immunodeficiency syndrome	0.000407	0.00586	CbGeAlD
Prazosin—ADRA1A—nervous system—acquired immunodeficiency syndrome	0.000405	0.00584	CbGeAlD
Prazosin—HTR1D—brain—acquired immunodeficiency syndrome	0.000403	0.00581	CbGeAlD
Prazosin—ABCG2—vagina—acquired immunodeficiency syndrome	0.000397	0.00573	CbGeAlD
Prazosin—Musculoskeletal discomfort—Zidovudine—acquired immunodeficiency syndrome	0.000393	0.00221	CcSEcCtD
Prazosin—Headache—Amprenavir—acquired immunodeficiency syndrome	0.000393	0.00221	CcSEcCtD
Prazosin—Palpitations—Delavirdine—acquired immunodeficiency syndrome	0.000393	0.0022	CcSEcCtD
Prazosin—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	0.000392	0.0022	CcSEcCtD
Prazosin—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.000391	0.0022	CcSEcCtD
Prazosin—KCNH2—nervous system—acquired immunodeficiency syndrome	0.000391	0.00564	CbGeAlD
Prazosin—Discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000391	0.00219	CcSEcCtD
Prazosin—Loss of consciousness—Delavirdine—acquired immunodeficiency syndrome	0.000391	0.00219	CcSEcCtD
Prazosin—Insomnia—Zidovudine—acquired immunodeficiency syndrome	0.00039	0.00219	CcSEcCtD
Prazosin—ADRA1A—central nervous system—acquired immunodeficiency syndrome	0.00039	0.00562	CbGeAlD
Prazosin—SLC22A3—brain—acquired immunodeficiency syndrome	0.000389	0.0056	CbGeAlD
Prazosin—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.000388	0.00218	CcSEcCtD
Prazosin—Hyperhidrosis—Indinavir—acquired immunodeficiency syndrome	0.000388	0.00218	CcSEcCtD
Prazosin—Paraesthesia—Zidovudine—acquired immunodeficiency syndrome	0.000387	0.00217	CcSEcCtD
Prazosin—Vision blurred—Ritonavir—acquired immunodeficiency syndrome	0.000387	0.00217	CcSEcCtD
Prazosin—Dry mouth—Efavirenz—acquired immunodeficiency syndrome	0.000387	0.00217	CcSEcCtD
Prazosin—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.000387	0.00217	CcSEcCtD
Prazosin—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	0.000385	0.00216	CcSEcCtD
Prazosin—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.000383	0.00215	CcSEcCtD
Prazosin—Alopecia—Lamivudine—acquired immunodeficiency syndrome	0.000383	0.00215	CcSEcCtD
Prazosin—Ill-defined disorder—Ritonavir—acquired immunodeficiency syndrome	0.000381	0.00214	CcSEcCtD
Prazosin—ADRA2A—blood—acquired immunodeficiency syndrome	0.000379	0.00547	CbGeAlD
Prazosin—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.000379	0.00213	CcSEcCtD
Prazosin—Arthralgia—Delavirdine—acquired immunodeficiency syndrome	0.000378	0.00212	CcSEcCtD
Prazosin—CYP1A1—vagina—acquired immunodeficiency syndrome	0.000377	0.00544	CbGeAlD
Prazosin—KCNH2—central nervous system—acquired immunodeficiency syndrome	0.000377	0.00543	CbGeAlD
Prazosin—ABCG2—lung—acquired immunodeficiency syndrome	0.000376	0.00541	CbGeAlD
Prazosin—SLC22A3—lymph node—acquired immunodeficiency syndrome	0.000375	0.00541	CbGeAlD
Prazosin—Discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000374	0.0021	CcSEcCtD
Prazosin—Shock—Efavirenz—acquired immunodeficiency syndrome	0.000373	0.00209	CcSEcCtD
Prazosin—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000372	0.00209	CcSEcCtD
Prazosin—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.000372	0.00209	CcSEcCtD
Prazosin—Malaise—Ritonavir—acquired immunodeficiency syndrome	0.000371	0.00208	CcSEcCtD
Prazosin—Tension—Lamivudine—acquired immunodeficiency syndrome	0.00037	0.00208	CcSEcCtD
Prazosin—Dry mouth—Delavirdine—acquired immunodeficiency syndrome	0.00037	0.00208	CcSEcCtD
Prazosin—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.00037	0.00208	CcSEcCtD
Prazosin—Vertigo—Ritonavir—acquired immunodeficiency syndrome	0.000369	0.00207	CcSEcCtD
Prazosin—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.000369	0.00207	CcSEcCtD
Prazosin—Pain—Zidovudine—acquired immunodeficiency syndrome	0.000369	0.00207	CcSEcCtD
Prazosin—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000369	0.00207	CcSEcCtD
Prazosin—Syncope—Ritonavir—acquired immunodeficiency syndrome	0.000369	0.00207	CcSEcCtD
Prazosin—Ill-defined disorder—Saquinavir—acquired immunodeficiency syndrome	0.000367	0.00206	CcSEcCtD
Prazosin—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000367	0.00206	CcSEcCtD
Prazosin—Nervousness—Lamivudine—acquired immunodeficiency syndrome	0.000366	0.00206	CcSEcCtD
Prazosin—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.000366	0.00206	CcSEcCtD
Prazosin—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000366	0.00205	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.000366	0.00205	CcSEcCtD
Prazosin—ADRA2A—spinal cord—acquired immunodeficiency syndrome	0.000365	0.00527	CbGeAlD
Prazosin—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000364	0.00204	CcSEcCtD
Prazosin—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000363	0.00204	CcSEcCtD
Prazosin—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.000363	0.00204	CcSEcCtD
Prazosin—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000363	0.00204	CcSEcCtD
Prazosin—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.000363	0.00204	CcSEcCtD
Prazosin—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	0.000361	0.00203	CcSEcCtD
Prazosin—Rash—Didanosine—acquired immunodeficiency syndrome	0.00036	0.00202	CcSEcCtD
Prazosin—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.00036	0.00202	CcSEcCtD
Prazosin—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.00036	0.00202	CcSEcCtD
Prazosin—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.00036	0.00202	CcSEcCtD
Prazosin—Headache—Didanosine—acquired immunodeficiency syndrome	0.000358	0.00201	CcSEcCtD
Prazosin—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000358	0.00201	CcSEcCtD
Prazosin—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000357	0.002	CcSEcCtD
Prazosin—Shock—Delavirdine—acquired immunodeficiency syndrome	0.000357	0.002	CcSEcCtD
Prazosin—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.000357	0.002	CcSEcCtD
Prazosin—CYP1A1—lung—acquired immunodeficiency syndrome	0.000357	0.00514	CbGeAlD
Prazosin—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000357	0.002	CcSEcCtD
Prazosin—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000356	0.002	CcSEcCtD
Prazosin—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000355	0.002	CcSEcCtD
Prazosin—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.000355	0.00199	CcSEcCtD
Prazosin—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.000355	0.00199	CcSEcCtD
Prazosin—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000354	0.00199	CcSEcCtD
Prazosin—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000352	0.00198	CcSEcCtD
Prazosin—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000352	0.00197	CcSEcCtD
Prazosin—ADRA2A—vagina—acquired immunodeficiency syndrome	0.000352	0.00507	CbGeAlD
Prazosin—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000351	0.00197	CcSEcCtD
Prazosin—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000351	0.00197	CcSEcCtD
Prazosin—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000351	0.00197	CcSEcCtD
Prazosin—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.00035	0.00197	CcSEcCtD
Prazosin—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.00035	0.00196	CcSEcCtD
Prazosin—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000348	0.00195	CcSEcCtD
Prazosin—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000346	0.00194	CcSEcCtD
Prazosin—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000346	0.00194	CcSEcCtD
Prazosin—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000346	0.00194	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000345	0.00194	CcSEcCtD
Prazosin—Pain—Indinavir—acquired immunodeficiency syndrome	0.000343	0.00193	CcSEcCtD
Prazosin—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000343	0.00193	CcSEcCtD
Prazosin—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000343	0.00192	CcSEcCtD
Prazosin—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000343	0.00192	CcSEcCtD
Prazosin—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000342	0.00192	CcSEcCtD
Prazosin—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000341	0.00191	CcSEcCtD
Prazosin—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000341	0.00191	CcSEcCtD
Prazosin—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.00034	0.00191	CcSEcCtD
Prazosin—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.00034	0.00191	CcSEcCtD
Prazosin—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.00034	0.00191	CcSEcCtD
Prazosin—Nausea—Didanosine—acquired immunodeficiency syndrome	0.00034	0.00191	CcSEcCtD
Prazosin—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000339	0.0019	CcSEcCtD
Prazosin—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000338	0.0019	CcSEcCtD
Prazosin—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000338	0.0019	CcSEcCtD
Prazosin—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000337	0.00189	CcSEcCtD
Prazosin—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000337	0.00189	CcSEcCtD
Prazosin—HTR1A—brain—acquired immunodeficiency syndrome	0.000336	0.00484	CbGeAlD
Prazosin—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000335	0.00188	CcSEcCtD
Prazosin—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000335	0.00188	CcSEcCtD
Prazosin—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000333	0.00187	CcSEcCtD
Prazosin—ADRA2A—lung—acquired immunodeficiency syndrome	0.000332	0.00479	CbGeAlD
Prazosin—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000332	0.00186	CcSEcCtD
Prazosin—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000331	0.00186	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.00033	0.00185	CcSEcCtD
Prazosin—CYP1A1—nervous system—acquired immunodeficiency syndrome	0.00033	0.00476	CbGeAlD
Prazosin—Shock—Ritonavir—acquired immunodeficiency syndrome	0.00033	0.00185	CcSEcCtD
Prazosin—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000329	0.00185	CcSEcCtD
Prazosin—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000329	0.00185	CcSEcCtD
Prazosin—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000328	0.00184	CcSEcCtD
Prazosin—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000328	0.00184	CcSEcCtD
Prazosin—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000327	0.00184	CcSEcCtD
Prazosin—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000327	0.00183	CcSEcCtD
Prazosin—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000327	0.00183	CcSEcCtD
Prazosin—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000326	0.00183	CcSEcCtD
Prazosin—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000324	0.00182	CcSEcCtD
Prazosin—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000324	0.00182	CcSEcCtD
Prazosin—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000324	0.00182	CcSEcCtD
Prazosin—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000324	0.00182	CcSEcCtD
Prazosin—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000324	0.00182	CcSEcCtD
Prazosin—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000323	0.00181	CcSEcCtD
Prazosin—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000323	0.00181	CcSEcCtD
Prazosin—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000323	0.00181	CcSEcCtD
Prazosin—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000322	0.00181	CcSEcCtD
Prazosin—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000322	0.00181	CcSEcCtD
Prazosin—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000321	0.0018	CcSEcCtD
Prazosin—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000319	0.00179	CcSEcCtD
Prazosin—CYP1A1—central nervous system—acquired immunodeficiency syndrome	0.000318	0.00458	CbGeAlD
Prazosin—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000318	0.00178	CcSEcCtD
Prazosin—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000317	0.00178	CcSEcCtD
Prazosin—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000317	0.00178	CcSEcCtD
Prazosin—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000317	0.00178	CcSEcCtD
Prazosin—ABCB1—retina—acquired immunodeficiency syndrome	0.000316	0.00455	CbGeAlD
Prazosin—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000316	0.00177	CcSEcCtD
Prazosin—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000314	0.00176	CcSEcCtD
Prazosin—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000314	0.00176	CcSEcCtD
Prazosin—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000314	0.00176	CcSEcCtD
Prazosin—Rash—Stavudine—acquired immunodeficiency syndrome	0.000313	0.00176	CcSEcCtD
Prazosin—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000313	0.00176	CcSEcCtD
Prazosin—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000313	0.00175	CcSEcCtD
Prazosin—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000312	0.00175	CcSEcCtD
Prazosin—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000312	0.00175	CcSEcCtD
Prazosin—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000312	0.00175	CcSEcCtD
Prazosin—Headache—Stavudine—acquired immunodeficiency syndrome	0.000311	0.00175	CcSEcCtD
Prazosin—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000311	0.00174	CcSEcCtD
Prazosin—Pain—Delavirdine—acquired immunodeficiency syndrome	0.00031	0.00174	CcSEcCtD
Prazosin—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.00031	0.00174	CcSEcCtD
Prazosin—ADRA1A—brain—acquired immunodeficiency syndrome	0.00031	0.00446	CbGeAlD
Prazosin—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.00031	0.00174	CcSEcCtD
Prazosin—Rash—Abacavir—acquired immunodeficiency syndrome	0.000308	0.00173	CcSEcCtD
Prazosin—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000308	0.00173	CcSEcCtD
Prazosin—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000308	0.00173	CcSEcCtD
Prazosin—ADRA2A—nervous system—acquired immunodeficiency syndrome	0.000308	0.00444	CbGeAlD
Prazosin—Headache—Abacavir—acquired immunodeficiency syndrome	0.000306	0.00172	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000306	0.00172	CcSEcCtD
Prazosin—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000305	0.00171	CcSEcCtD
Prazosin—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000305	0.00171	CcSEcCtD
Prazosin—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000303	0.0017	CcSEcCtD
Prazosin—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000303	0.0017	CcSEcCtD
Prazosin—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000301	0.00169	CcSEcCtD
Prazosin—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000301	0.00169	CcSEcCtD
Prazosin—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.0003	0.00168	CcSEcCtD
Prazosin—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000299	0.00168	CcSEcCtD
Prazosin—KCNH2—brain—acquired immunodeficiency syndrome	0.000299	0.00431	CbGeAlD
Prazosin—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000299	0.00168	CcSEcCtD
Prazosin—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000298	0.00167	CcSEcCtD
Prazosin—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000298	0.00167	CcSEcCtD
Prazosin—ADRA2A—central nervous system—acquired immunodeficiency syndrome	0.000296	0.00427	CbGeAlD
Prazosin—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000296	0.00166	CcSEcCtD
Prazosin—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000296	0.00166	CcSEcCtD
Prazosin—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000295	0.00166	CcSEcCtD
Prazosin—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000295	0.00165	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000294	0.00165	CcSEcCtD
Prazosin—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000292	0.00164	CcSEcCtD
Prazosin—Nausea—Abacavir—acquired immunodeficiency syndrome	0.00029	0.00163	CcSEcCtD
Prazosin—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.00029	0.00163	CcSEcCtD
Prazosin—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000289	0.00162	CcSEcCtD
Prazosin—KCNH2—lymph node—acquired immunodeficiency syndrome	0.000289	0.00416	CbGeAlD
Prazosin—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000288	0.00162	CcSEcCtD
Prazosin—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000288	0.00162	CcSEcCtD
Prazosin—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000288	0.00162	CcSEcCtD
Prazosin—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000287	0.00161	CcSEcCtD
Prazosin—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000287	0.00161	CcSEcCtD
Prazosin—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000287	0.00161	CcSEcCtD
Prazosin—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000287	0.00161	CcSEcCtD
Prazosin—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000285	0.0016	CcSEcCtD
Prazosin—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000284	0.00159	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000281	0.00157	CcSEcCtD
Prazosin—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000279	0.00157	CcSEcCtD
Prazosin—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000279	0.00156	CcSEcCtD
Prazosin—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000278	0.00156	CcSEcCtD
Prazosin—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000277	0.00155	CcSEcCtD
Prazosin—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000276	0.00155	CcSEcCtD
Prazosin—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000276	0.00155	CcSEcCtD
Prazosin—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000276	0.00155	CcSEcCtD
Prazosin—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000275	0.00154	CcSEcCtD
Prazosin—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000274	0.00154	CcSEcCtD
Prazosin—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000274	0.00154	CcSEcCtD
Prazosin—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000274	0.00154	CcSEcCtD
Prazosin—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000272	0.00153	CcSEcCtD
Prazosin—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000272	0.00153	CcSEcCtD
Prazosin—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000272	0.00153	CcSEcCtD
Prazosin—Headache—Zidovudine—acquired immunodeficiency syndrome	0.00027	0.00152	CcSEcCtD
Prazosin—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000268	0.00151	CcSEcCtD
Prazosin—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000267	0.0015	CcSEcCtD
Prazosin—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000266	0.0015	CcSEcCtD
Prazosin—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000266	0.00149	CcSEcCtD
Prazosin—ABCG2—brain—acquired immunodeficiency syndrome	0.000266	0.00383	CbGeAlD
Prazosin—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000265	0.00149	CcSEcCtD
Prazosin—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000265	0.00149	CcSEcCtD
Prazosin—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000265	0.00149	CcSEcCtD
Prazosin—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000263	0.00148	CcSEcCtD
Prazosin—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000263	0.00148	CcSEcCtD
Prazosin—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.00026	0.00146	CcSEcCtD
Prazosin—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000259	0.00146	CcSEcCtD
Prazosin—ABCG2—lymph node—acquired immunodeficiency syndrome	0.000257	0.0037	CbGeAlD
Prazosin—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000257	0.00144	CcSEcCtD
Prazosin—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000256	0.00144	CcSEcCtD
Prazosin—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000256	0.00144	CcSEcCtD
Prazosin—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000255	0.00143	CcSEcCtD
Prazosin—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000255	0.00143	CcSEcCtD
Prazosin—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000254	0.00142	CcSEcCtD
Prazosin—Rash—Indinavir—acquired immunodeficiency syndrome	0.000253	0.00142	CcSEcCtD
Prazosin—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000253	0.00142	CcSEcCtD
Prazosin—CYP1A1—brain—acquired immunodeficiency syndrome	0.000252	0.00364	CbGeAlD
Prazosin—Headache—Indinavir—acquired immunodeficiency syndrome	0.000251	0.00141	CcSEcCtD
Prazosin—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000251	0.00141	CcSEcCtD
Prazosin—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000248	0.00139	CcSEcCtD
Prazosin—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000247	0.00139	CcSEcCtD
Prazosin—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000245	0.00137	CcSEcCtD
Prazosin—CYP1A1—lymph node—acquired immunodeficiency syndrome	0.000244	0.00352	CbGeAlD
Prazosin—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000243	0.00137	CcSEcCtD
Prazosin—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000241	0.00135	CcSEcCtD
Prazosin—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000241	0.00135	CcSEcCtD
Prazosin—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.00024	0.00135	CcSEcCtD
Prazosin—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000239	0.00134	CcSEcCtD
Prazosin—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000239	0.00134	CcSEcCtD
Prazosin—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000238	0.00134	CcSEcCtD
Prazosin—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000238	0.00133	CcSEcCtD
Prazosin—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000237	0.00133	CcSEcCtD
Prazosin—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000237	0.00133	CcSEcCtD
Prazosin—ADRA2A—brain—acquired immunodeficiency syndrome	0.000235	0.00339	CbGeAlD
Prazosin—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000232	0.0013	CcSEcCtD
Prazosin—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000231	0.00129	CcSEcCtD
Prazosin—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000229	0.00129	CcSEcCtD
Prazosin—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000229	0.00128	CcSEcCtD
Prazosin—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000228	0.00128	CcSEcCtD
Prazosin—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000228	0.00128	CcSEcCtD
Prazosin—ADRA2A—lymph node—acquired immunodeficiency syndrome	0.000227	0.00328	CbGeAlD
Prazosin—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000227	0.00128	CcSEcCtD
Prazosin—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000227	0.00127	CcSEcCtD
Prazosin—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000225	0.00126	CcSEcCtD
Prazosin—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	0.000225	0.00324	CbGeAlD
Prazosin—ABCB1—digestive system—acquired immunodeficiency syndrome	0.000222	0.0032	CbGeAlD
Prazosin—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000222	0.00124	CcSEcCtD
Prazosin—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000221	0.00124	CcSEcCtD
Prazosin—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000221	0.00124	CcSEcCtD
Prazosin—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000218	0.00122	CcSEcCtD
Prazosin—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000215	0.00121	CcSEcCtD
Prazosin—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000213	0.0012	CcSEcCtD
Prazosin—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000213	0.0012	CcSEcCtD
Prazosin—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000211	0.00119	CcSEcCtD
Prazosin—ABCB1—blood—acquired immunodeficiency syndrome	0.000211	0.00305	CbGeAlD
Prazosin—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000211	0.00119	CcSEcCtD
Prazosin—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000211	0.00118	CcSEcCtD
Prazosin—Headache—Ritonavir—acquired immunodeficiency syndrome	0.00021	0.00118	CcSEcCtD
Prazosin—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000205	0.00115	CcSEcCtD
Prazosin—ABCB1—bone marrow—acquired immunodeficiency syndrome	0.000204	0.00295	CbGeAlD
Prazosin—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000204	0.00114	CcSEcCtD
Prazosin—ABCB1—spinal cord—acquired immunodeficiency syndrome	0.000204	0.00293	CbGeAlD
Prazosin—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000204	0.00114	CcSEcCtD
Prazosin—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000203	0.00114	CcSEcCtD
Prazosin—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000202	0.00114	CcSEcCtD
Prazosin—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000199	0.00112	CcSEcCtD
Prazosin—ABCB1—vagina—acquired immunodeficiency syndrome	0.000196	0.00282	CbGeAlD
Prazosin—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000196	0.0011	CcSEcCtD
Prazosin—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000194	0.00109	CcSEcCtD
Prazosin—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000194	0.00109	CcSEcCtD
Prazosin—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000193	0.00108	CcSEcCtD
Prazosin—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000192	0.00108	CcSEcCtD
Prazosin—ABCB1—lung—acquired immunodeficiency syndrome	0.000185	0.00267	CbGeAlD
Prazosin—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000183	0.00103	CcSEcCtD
Prazosin—ABCB1—nervous system—acquired immunodeficiency syndrome	0.000172	0.00247	CbGeAlD
Prazosin—ABCB1—central nervous system—acquired immunodeficiency syndrome	0.000165	0.00238	CbGeAlD
Prazosin—ABCB1—brain—acquired immunodeficiency syndrome	0.000131	0.00189	CbGeAlD
Prazosin—ABCB1—lymph node—acquired immunodeficiency syndrome	0.000127	0.00183	CbGeAlD
Prazosin—ADRA1D—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	2.37e-05	0.00156	CbGpPWpGaD
Prazosin—ADRA2A—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	2.37e-05	0.00156	CbGpPWpGaD
Prazosin—ADRA2A—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	2.37e-05	0.00156	CbGpPWpGaD
Prazosin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	2.36e-05	0.00156	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	2.33e-05	0.00153	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	2.33e-05	0.00153	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	2.31e-05	0.00152	CbGpPWpGaD
Prazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	2.29e-05	0.00151	CbGpPWpGaD
Prazosin—HTR1A—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	2.29e-05	0.00151	CbGpPWpGaD
Prazosin—HTR1D—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	2.28e-05	0.0015	CbGpPWpGaD
Prazosin—HTR1D—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	2.28e-05	0.0015	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	2.25e-05	0.00148	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	2.25e-05	0.00148	CbGpPWpGaD
Prazosin—SLC22A2—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	2.23e-05	0.00147	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	2.2e-05	0.00145	CbGpPWpGaD
Prazosin—ADRA1B—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	2.18e-05	0.00144	CbGpPWpGaD
Prazosin—ADRA2B—Platelet activation, signaling and aggregation—IL2—acquired immunodeficiency syndrome	2.14e-05	0.00141	CbGpPWpGaD
Prazosin—ADRA2B—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	2.14e-05	0.00141	CbGpPWpGaD
Prazosin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	2.13e-05	0.0014	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	2.11e-05	0.00139	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	2.09e-05	0.00138	CbGpPWpGaD
Prazosin—ADRA2B—Hemostasis—CSF2—acquired immunodeficiency syndrome	2.09e-05	0.00138	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	2.08e-05	0.00137	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—TAT—acquired immunodeficiency syndrome	2.08e-05	0.00137	CbGpPWpGaD
Prazosin—SLC22A1—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	2.08e-05	0.00137	CbGpPWpGaD
Prazosin—ADRA1D—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	2.08e-05	0.00137	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	2.07e-05	0.00136	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	2.07e-05	0.00136	CbGpPWpGaD
Prazosin—HTR1A—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	2.06e-05	0.00136	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—AGPS—acquired immunodeficiency syndrome	2.04e-05	0.00134	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—IFNA1—acquired immunodeficiency syndrome	2.03e-05	0.00133	CbGpPWpGaD
Prazosin—ADRA2A—Platelet activation, signaling and aggregation—ALB—acquired immunodeficiency syndrome	2e-05	0.00132	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	1.99e-05	0.00131	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	1.99e-05	0.00131	CbGpPWpGaD
Prazosin—HTR1A—SIDS Susceptibility Pathways—TNF—acquired immunodeficiency syndrome	1.99e-05	0.00131	CbGpPWpGaD
Prazosin—ADRA1B—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	1.97e-05	0.00129	CbGpPWpGaD
Prazosin—ADRA1D—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	1.95e-05	0.00129	CbGpPWpGaD
Prazosin—ADRA1D—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	1.95e-05	0.00129	CbGpPWpGaD
Prazosin—ADRA1A—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	1.94e-05	0.00128	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	1.89e-05	0.00124	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	1.88e-05	0.00124	CbGpPWpGaD
Prazosin—ADRA2B—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	1.87e-05	0.00123	CbGpPWpGaD
Prazosin—ABCB1—Allograft Rejection—TNF—acquired immunodeficiency syndrome	1.86e-05	0.00123	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	1.82e-05	0.0012	CbGpPWpGaD
Prazosin—HTR1A—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	1.81e-05	0.00119	CbGpPWpGaD
Prazosin—SLC22A3—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.81e-05	0.00119	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	1.8e-05	0.00119	CbGpPWpGaD
Prazosin—ADRA2A—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	1.8e-05	0.00119	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	1.8e-05	0.00118	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	1.8e-05	0.00118	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	1.77e-05	0.00117	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	1.77e-05	0.00117	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—AGPS—acquired immunodeficiency syndrome	1.77e-05	0.00116	CbGpPWpGaD
Prazosin—ADRA2B—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	1.76e-05	0.00116	CbGpPWpGaD
Prazosin—ADRA2B—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	1.76e-05	0.00116	CbGpPWpGaD
Prazosin—ADRA1A—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	1.75e-05	0.00115	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	1.74e-05	0.00114	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	1.74e-05	0.00114	CbGpPWpGaD
Prazosin—HTR1D—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.74e-05	0.00114	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	1.73e-05	0.00114	CbGpPWpGaD
Prazosin—ADRA1B—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	1.72e-05	0.00113	CbGpPWpGaD
Prazosin—HTR1D—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.71e-05	0.00113	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	1.7e-05	0.00112	CbGpPWpGaD
Prazosin—HTR1A—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	1.7e-05	0.00112	CbGpPWpGaD
Prazosin—HTR1A—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	1.7e-05	0.00112	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—TAT—acquired immunodeficiency syndrome	1.66e-05	0.00109	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	1.65e-05	0.00109	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	1.65e-05	0.00109	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	1.64e-05	0.00108	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	1.63e-05	0.00107	CbGpPWpGaD
Prazosin—ADRA2A—Platelet activation, signaling and aggregation—IL2—acquired immunodeficiency syndrome	1.63e-05	0.00107	CbGpPWpGaD
Prazosin—ADRA2A—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	1.62e-05	0.00107	CbGpPWpGaD
Prazosin—ADRA1B—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	1.62e-05	0.00107	CbGpPWpGaD
Prazosin—ADRA1B—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	1.62e-05	0.00107	CbGpPWpGaD
Prazosin—HTR1A—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	1.61e-05	0.00106	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	1.6e-05	0.00105	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	1.6e-05	0.00105	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—CSF2—acquired immunodeficiency syndrome	1.59e-05	0.00104	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.58e-05	0.00104	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	1.57e-05	0.00103	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	1.56e-05	0.00103	CbGpPWpGaD
Prazosin—HTR1D—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.56e-05	0.00103	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.55e-05	0.00102	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	1.55e-05	0.00102	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	1.55e-05	0.00102	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	1.54e-05	0.00101	CbGpPWpGaD
Prazosin—ADRA1A—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	1.53e-05	0.00101	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	1.5e-05	0.000985	CbGpPWpGaD
Prazosin—ADRA1D—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.49e-05	0.000978	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	1.47e-05	0.000969	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	1.47e-05	0.000969	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	1.47e-05	0.000968	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	1.47e-05	0.000968	CbGpPWpGaD
Prazosin—ADRA1D—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.46e-05	0.000963	CbGpPWpGaD
Prazosin—ADRA1A—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	1.44e-05	0.000947	CbGpPWpGaD
Prazosin—ADRA1A—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	1.44e-05	0.000947	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.44e-05	0.000947	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	1.43e-05	0.00094	CbGpPWpGaD
Prazosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	1.43e-05	0.000939	CbGpPWpGaD
Prazosin—ADRA2A—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	1.42e-05	0.000936	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.42e-05	0.000935	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—AGPS—acquired immunodeficiency syndrome	1.41e-05	0.00093	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	1.39e-05	0.000915	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	1.37e-05	0.000899	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	1.37e-05	0.000899	CbGpPWpGaD
Prazosin—ADRA2B—Hemostasis—ALB—acquired immunodeficiency syndrome	1.36e-05	0.000897	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.35e-05	0.000888	CbGpPWpGaD
Prazosin—ADRA2B—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.34e-05	0.000883	CbGpPWpGaD
Prazosin—ADRA1D—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.34e-05	0.000881	CbGpPWpGaD
Prazosin—ADRA2A—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	1.34e-05	0.00088	CbGpPWpGaD
Prazosin—ADRA2A—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	1.34e-05	0.00088	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	1.33e-05	0.000875	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.33e-05	0.000875	CbGpPWpGaD
Prazosin—ADRA2B—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.32e-05	0.000869	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	1.31e-05	0.00086	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	1.31e-05	0.00086	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.3e-05	0.000857	CbGpPWpGaD
Prazosin—HTR1A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.29e-05	0.000852	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	1.29e-05	0.00085	CbGpPWpGaD
Prazosin—HTR1A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.27e-05	0.000839	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	1.23e-05	0.000813	CbGpPWpGaD
Prazosin—ADRA1B—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.23e-05	0.000811	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.23e-05	0.000811	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.22e-05	0.000805	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.22e-05	0.000805	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.22e-05	0.000802	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.22e-05	0.0008	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	1.21e-05	0.000799	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	1.21e-05	0.000799	CbGpPWpGaD
Prazosin—ADRA1B—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.21e-05	0.000799	CbGpPWpGaD
Prazosin—ADRA2B—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.21e-05	0.000795	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.2e-05	0.00079	CbGpPWpGaD
Prazosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	1.18e-05	0.000779	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.18e-05	0.000774	CbGpPWpGaD
Prazosin—HTR1A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.17e-05	0.000768	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.16e-05	0.000762	CbGpPWpGaD
Prazosin—ABCG2—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.14e-05	0.000753	CbGpPWpGaD
Prazosin—SLC22A2—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.13e-05	0.000745	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.12e-05	0.000737	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.11e-05	0.000733	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.11e-05	0.000732	CbGpPWpGaD
Prazosin—ADRA1B—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.11e-05	0.000731	CbGpPWpGaD
Prazosin—ADRA2B—Hemostasis—IL2—acquired immunodeficiency syndrome	1.1e-05	0.000727	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.1e-05	0.000726	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.1e-05	0.000722	CbGpPWpGaD
Prazosin—ADRA1A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.09e-05	0.000721	CbGpPWpGaD
Prazosin—ADRA1A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.08e-05	0.00071	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.07e-05	0.000707	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.06e-05	0.000697	CbGpPWpGaD
Prazosin—SLC22A1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.06e-05	0.000695	CbGpPWpGaD
Prazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	1.05e-05	0.000692	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.05e-05	0.000689	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.05e-05	0.000689	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—ALB—acquired immunodeficiency syndrome	1.03e-05	0.00068	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.02e-05	0.000673	CbGpPWpGaD
Prazosin—ADRA2A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.02e-05	0.00067	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.01e-05	0.000664	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.01e-05	0.000662	CbGpPWpGaD
Prazosin—ADRA2A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1e-05	0.00066	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	9.94e-06	0.000655	CbGpPWpGaD
Prazosin—ADRA1A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	9.86e-06	0.000649	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	9.79e-06	0.000645	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	9.71e-06	0.000639	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	9.45e-06	0.000622	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	9.45e-06	0.000622	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	9.31e-06	0.000613	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	9.24e-06	0.000609	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	9.24e-06	0.000608	CbGpPWpGaD
Prazosin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	9.2e-06	0.000606	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	9.17e-06	0.000604	CbGpPWpGaD
Prazosin—ADRA2A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	9.17e-06	0.000603	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	9.13e-06	0.000601	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	9.13e-06	0.000601	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	9.1e-06	0.000599	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	9.08e-06	0.000598	CbGpPWpGaD
Prazosin—HTR1D—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	9.03e-06	0.000595	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	8.96e-06	0.00059	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	8.69e-06	0.000572	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	8.69e-06	0.000572	CbGpPWpGaD
Prazosin—SLC22A3—Metabolism—ALB—acquired immunodeficiency syndrome	8.46e-06	0.000557	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	8.44e-06	0.000555	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8.39e-06	0.000552	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—IL2—acquired immunodeficiency syndrome	8.38e-06	0.000552	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	8.32e-06	0.000548	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	8.21e-06	0.000541	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	8.2e-06	0.00054	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	8.14e-06	0.000536	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	7.97e-06	0.000524	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	7.85e-06	0.000517	CbGpPWpGaD
Prazosin—ADRA1D—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	7.73e-06	0.000509	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	7.72e-06	0.000508	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	7.72e-06	0.000508	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	7.63e-06	0.000502	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	7.19e-06	0.000473	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	7.18e-06	0.000472	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	7.17e-06	0.000472	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	7.17e-06	0.000472	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	7.09e-06	0.000466	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	7.02e-06	0.000462	CbGpPWpGaD
Prazosin—ADRA2B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	6.98e-06	0.000459	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	6.94e-06	0.000457	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	6.84e-06	0.00045	CbGpPWpGaD
Prazosin—HTR1A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	6.74e-06	0.000444	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	6.61e-06	0.000435	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	6.51e-06	0.000429	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	6.48e-06	0.000427	CbGpPWpGaD
Prazosin—ADRA1B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	6.42e-06	0.000422	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	6.34e-06	0.000417	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	6.26e-06	0.000412	CbGpPWpGaD
Prazosin—ABCB1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	6.19e-06	0.000407	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	6.12e-06	0.000403	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	5.96e-06	0.000392	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	5.87e-06	0.000387	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	5.83e-06	0.000384	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	5.79e-06	0.000381	CbGpPWpGaD
Prazosin—ADRA1A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	5.7e-06	0.000375	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	5.46e-06	0.000359	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	5.38e-06	0.000354	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—ALB—acquired immunodeficiency syndrome	5.36e-06	0.000353	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—ALB—acquired immunodeficiency syndrome	5.3e-06	0.000349	CbGpPWpGaD
Prazosin—ADRA2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	5.3e-06	0.000349	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	5.29e-06	0.000348	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	5.18e-06	0.000341	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—ALB—acquired immunodeficiency syndrome	4.94e-06	0.000325	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	4.92e-06	0.000324	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.85e-06	0.000319	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.82e-06	0.000317	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	4.81e-06	0.000317	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—ALB—acquired immunodeficiency syndrome	4.19e-06	0.000276	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.15e-06	0.000273	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.13e-06	0.000272	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.74e-06	0.000246	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.73e-06	0.000245	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—ALB—acquired immunodeficiency syndrome	3.63e-06	0.000239	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.61e-06	0.000238	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.6e-06	0.000237	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.44e-06	0.000227	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.42e-06	0.000225	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.06e-06	0.000201	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.04e-06	0.0002	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—ALB—acquired immunodeficiency syndrome	2.9e-06	0.000191	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.85e-06	0.000187	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	2.84e-06	0.000187	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	2.83e-06	0.000186	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.44e-06	0.00016	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.2e-06	0.000145	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.12e-06	0.00014	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.02e-06	0.000133	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.8e-06	0.000118	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.67e-06	0.00011	CbGpPWpGaD
